V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210036131 | 210038525 | 1.56 | 28.2 | Curative (C) | 2015-08-09 | 2015-10-18 | PONATINIB | N | N | 210037781 | PONATINIB |
| 210036132 | 210012881 | 0 | null | Curative (C) | 2017-05-31 | 2017-06-01 | Inotuzumab Ozogamicin | N | N | 210037785 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210036133 | 210012890 | 1.63 | 13.4 | Curative (C) | 2017-12-07 | 2018-04-25 | RIALTO TRIAL | N | N | 210037803 | BENDAMUSTINE |
| 210036134 | 210012909 | 1.72 | 62.1 | Palliative (P) | 2018-08-03 | 2018-08-12 | IDELALISIB | 02 | N | 210037983 | CVP R |
| 210036135 | 210012918 | 1.78 | 27.4 | Palliative (P) | null | 2018-06-12 | PONATINIB | null | null | 210038029 | PONATINIB |
| 210036136 | 210012945 | 1.87 | 84.2 | Palliative (P) | 2018-05-23 | 2018-05-30 | CHOP - 21 days | N | N | 210038157 | METHOTREXATE HIGH DOSE |
| 210036137 | 210022154 | 1.72 | 12.9 | Palliative (P) | null | 2015-07-19 | Carboplatin + Etoposide iv&po | Y | N | 210038174 | BENDAMUSTINE |
| 210036138 | 210012955 | 1.68 | 63.7 | Adjuvant (A) | 2019-10-18 | 2020-02-17 | CLADRIBINE | Y | N | 210038187 | CLADRIBINE |
| 210036139 | 210012960 | 1.1 | 90 | Curative (C) | 2016-01-29 | 2016-06-18 | Procarbazine | 01 | null | 210038211 | PROCARBAZINE |
| 210036140 | 210012964 | null | 93.8 | Curative (C) | 2016-03-07 | 2016-05-04 | LOMUSTINE + PROCARBAZINE | N | N | 210038222 | LOMUSTINE + PROCARBAZINE |
| 210036141 | 210012985 | 0 | 61.1 | null | 2016-11-04 | 2016-11-14 | CARBOPLATIN + VINCRISTINE | N | N | 210038312 | CARBOPLATIN + VINCRISTINE |
| 210036142 | 210013003 | 1.77 | 16 | Curative (C) | 2014-01-30 | 2014-01-30 | CNS LGG 2004 03 vinc weekly+ carbo | 02 | N | 210038363 | CARBOPLATIN + VINCRISTINE |
| 210036143 | 210027928 | 1.66 | null | Palliative (P) | 2018-01-11 | 2018-07-26 | Carboplatin + Etoposide IV 3 day | N | N | 210038500 | BENDAMUSTINE |
| 210036144 | 210013038 | null | 79.8 | Palliative (P) | 2018-12-27 | 2019-05-21 | Vinblastine weekly | 01 | N | 210038553 | VINBLASTINE |
| 210036145 | 210031426 | null | 53 | null | 2014-07-13 | 2014-07-18 | BENDAMUSTINE | N | N | 210038557 | CVP R |
| 210036146 | 210013063 | null | null | Palliative (P) | 2018-01-26 | 2018-03-01 | LOMUSTINE + PROCARBAZINE | N | null | 210038656 | LOMUSTINE + PROCARBAZINE |
| 210036147 | 210013068 | null | 107.7 | Disease modification (D) | 2018-05-04 | 2018-05-07 | PONATINIB | N | N | 210038669 | ERWINIA ASPARAGINASE |
| 210036148 | 210013091 | 1.76 | 97.9 | Curative (C) | 2016-01-09 | 2016-01-09 | RIALTO TRIAL | Y | N | 210038791 | CHLORAMBUCIL + OFATUMUMAB |
| 210036149 | 210013108 | 1.69 | null | Palliative (P) | 2018-04-18 | 2018-04-20 | Bendamustine +/- Prednisolone | 02 | N | 210038851 | CHLORAMBUCIL + OFATUMUMAB |
| 210036150 | 210013114 | 1.51 | 16.9 | Palliative (P) | 2016-11-23 | 2016-11-23 | Procarbazine | N | N | 210038885 | PROCARBAZINE |
| 210036151 | 210013133 | 1.85 | 23.2 | Curative (C) | 2017-08-01 | 2017-08-02 | LOMUSTINE + PROCARBAZINE | 99 | N | 210038940 | LOMUSTINE + PROCARBAZINE |
| 210036152 | 210013145 | 1.77 | 73.2 | Curative (C) | 2019-12-27 | 2020-01-01 | Carboplatin + Etoposide iv&po | 2 | N | 210039036 | IDELALISIB |
| 210036153 | 210013152 | 1.7 | 54.9 | Curative (C) | 2017-04-27 | 2017-04-27 | LOMUSTINE + PROCARBAZINE | N | N | 210039055 | LOMUSTINE + PROCARBAZINE |
| 210036154 | 210013167 | 1.72 | 66.7 | Palliative (P) | 2014-05-07 | 2014-05-07 | Inotuzumab Ozogamicin | N | null | 210039110 | CVP R |
| 210036155 | 210022268 | 1.6 | 68.7 | Curative (C) | 2017-07-04 | 2018-03-11 | ATG + Busulfan + Fludarabine | Y | N | 210039158 | BORTEZOMIB |
| 210036156 | 210013179 | 1.73 | 66.5 | null | 2018-12-21 | 2019-06-30 | Cyclophosphamide High Dose | null | N | 210039177 | TRASTUZUMAB |
| 210036157 | 210013183 | 1.63 | 47 | Curative (C) | 2016-10-06 | 2017-08-18 | Paclitaxel (2 or 3 weekly) | N | N | 210039186 | DOCETAXEL |
| 210036158 | 210027977 | 1.69 | 87.8 | Curative (C) | 2014-12-12 | 2015-02-16 | CISPLATIN + ETOPOSIDE | N | N | 210039212 | TAVAREC TRIAL |
| 210036159 | 210013190 | 1.85 | 99 | Curative (C) | 2017-02-27 | 2017-09-26 | Irinotecan | N | N | 210039213 | BR14 TRIAL |
| 210036160 | 210013212 | 1.6 | null | Curative (C) | 2015-08-02 | 2016-02-12 | Dactinomycin + Vincristine | N | N | 210039328 | BCG |
| 210036161 | 210013239 | null | 84.7 | Curative (C) | 2016-05-23 | 2016-05-28 | CLARITY Trial | N | null | 210039434 | CISPLATIN + LOMUSTINE + VINCRISTINE |
| 210036162 | 210022319 | 1.65 | 47.9 | Curative (C) | 2019-02-04 | 2019-02-11 | BR14 TRIAL | Y | N | 210039592 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 210036163 | 210013259 | 1.65 | 67.85 | Curative (C) | 2015-09-15 | 2016-03-29 | Alemtuzumab + Cyclophos TBI Allo | null | null | 210039601 | IRINOTECAN + TEMOZOLOMIDE |
| 210036164 | 210013271 | 1.83 | 59.8 | Curative (C) | 2019-03-29 | 2019-04-09 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | Y | N | 210039685 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210036165 | 210013286 | 1.78 | 73 | Curative (C) | 2014-06-23 | 2014-06-23 | CLL210 TRIAL | N | null | 210039746 | PACLITAXEL |
| 210036166 | 210013315 | null | null | Curative (C) | 2016-08-27 | 2017-01-25 | CAV | null | null | 210039899 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210036167 | 210013324 | 1.6 | null | Adjuvant (A) | 2014-12-02 | 2015-01-12 | BEAM | N | N | 210039964 | CYCLO + ETOPOSIDE + NELARABINE |
| 210036168 | 210013347 | null | 79.6 | Curative (C) | 2016-06-01 | 2016-11-30 | Irinotecan | 02 | N | 210040057 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210036169 | 210013359 | 0 | 70.2 | Disease modification (D) | 2014-03-27 | 2016-01-19 | Fludarabine IV | N | null | 210040136 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210036170 | 210013395 | 1.58 | 78.5 | null | 2013-12-02 | 2013-12-02 | Alemtuzumab + Cyclophos TBI Allo | N | N | 210040494 | MITOMYCIN INTRAVESICULAR |
| 210036171 | 210013417 | null | 68.2 | Curative (C) | 2017-03-03 | 2017-12-03 | Alemtuzumab + Cyclophos TBI Allo | N | null | 210040628 | PACKER MAINTENANCE |
| 210036172 | 210013432 | 1.59 | 65 | Curative (C) | 2017-03-17 | 2017-03-17 | Fludarabine oral | N | N | 210040696 | DOCETAXEL |
| 210036173 | 210013434 | 1.72 | 10.5 | Curative (C) | 2016-11-22 | 2016-12-09 | BR14 TRIAL | N | null | 210040699 | BEVACIZUMAB + IRINOTECAN |
| 210036174 | 210013442 | 1.68 | null | null | 2014-05-03 | 2014-05-03 | PIXANTRONE | 99 | N | 210040728 | CISPLATIN |
| 210036175 | 210013482 | null | 73.5 | Curative (C) | 2018-04-15 | 2018-07-13 | ESHAP | N | null | 210040958 | CISPLATIN + ETOPOSIDE |
| 210036176 | 210013492 | 1.82 | 63.5 | Palliative (P) | 2014-11-01 | 2014-11-02 | Packer Maintenance Regimen | N | N | 210041021 | METHOTREXATE + VINCRISTINE |
| 210036177 | 210022461 | 1.75 | 81.8 | Palliative (P) | 2015-04-13 | 2015-04-24 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 02 | N | 210041122 | ICE |
| 210036178 | 210013527 | 1.64 | 54 | Curative (C) | 2019-04-21 | 2019-05-20 | FLUDARABINE + MITOXANTRONE | 2 | N | 210041199 | BR14 TRIAL |
| 210036179 | 210013549 | 0 | null | Curative (C) | null | 2016-11-10 | Depocyte Intrathecal | N | N | 210041357 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 210036180 | 210013563 | 0 | 17.7 | Disease modification (D) | 2015-02-20 | 2015-02-21 | FLAG | 2 | N | 210041423 | MPT |